AIA
RDY icon

Alera Investment Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History

Alera Investment Advisors’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-2,545
Closed -$21K – 791
2019
Q1 		$21K Buy
2,545
+375
+17% +$2.85K 0.01% 287
2018
Q4 		$16K Buy
+2,170
New +$15.3K 0.01% 338

Other funds holding RDY

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

Alera Investment Advisors's RDY Position: Q2 2019 in Review

Alera Investment Advisors sold out of Dr. Reddy's Laboratories (RDY) in Q2 2019, closing a stake of 2,545 shares — an estimated $21K sold.

Alera Investment Advisors first reported a position in RDY in Q4 2018 and held it in 2 quarters. The position peaked at $21K in Q1 2019. 150 funds tracked by Wall St. Rank hold RDY as of Q2 2019.

  • Alera Investment Advisors reported no remaining Dr. Reddy's Laboratories position as of Q2 2019 after selling out during the quarter.
  • Alera Investment Advisors sold 2,545 Dr. Reddy's Laboratories shares in Q2 2019, an estimated $21K.
  • Alera Investment Advisors first reported a position in Dr. Reddy's Laboratories in Q4 2018 and held it in 2 quarters.
  • Alera Investment Advisors's Dr. Reddy's Laboratories position peaked at $21K in Q1 2019.
  • 150 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2019.

Based on Alera Investment Advisors's 13F filing for Q2 2019, filed 7 Aug 2019.